Test Price
2,800 AED✅ Home Collection Available
MTOR Gene Sequencing for Neurodevelopmental Disorders in UAE | 2,800 AED | DHA Licensed Laboratory
Executive Summary & Core Metrics
The MTOR Gene Sequencing test delivers advanced genomic analysis to detect pathogenic variants associated with neurodevelopmental disorders, achieving 99.9% diagnostic sensitivity through ISO 9001:2015 certified cold‑chain processing. VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM. Post‑test genetic counselling with a DHA‑licensed genetic counsellor is included. Direct insurance billing verification via WhatsApp.
- ✔ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Cold‑Chain Processing.
- ✔ Premium Logistics: Hospital‑Grade Home Collection & VIP Mobile Phlebotomy (8 AM – 11 PM).
- ✔ Clinical Guidance: Telephonic Post‑Test Genetic Counselling with DHA‑Licensed Genetic Counsellor.
- ✔ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The MTOR gene sequencing test analyzes the entire coding region of the MTOR gene using Next‑Generation Sequencing (NGS) to detect pathogenic variants associated with neurodevelopmental disorders, including macrocephaly, intellectual disability, and epilepsy. This definitive molecular diagnosis empowers clinicians to tailor surveillance, therapy, and familial recurrence risk counselling in full compliance with DHA standards. All results are confirmed by Sanger sequencing to ensure 99.9% accuracy.
| Feature | Our Test – NGS Pro | Closest Alternative (Sanger‑only) |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) + Sanger confirmation | Sanger sequencing (limited hotspot regions) |
| Gene Coverage | All exons & splice sites of MTOR | Selected exons only |
| Turnaround Time | 3‑4 weeks | 6‑8 weeks |
| Sample & Logistics | Blood, DNA, or FTA card – Home collection available | Blood only – In‑clinic draw |
Physician Insight & Safety Protocols
“This genomic test provides a molecular window into the etiology of neurodevelopmental disorders, enabling precise diagnosis and targeted management. Results must be interpreted in conjunction with detailed clinical phenotyping and post‑test genetic counselling to guide therapeutic decisions and family planning.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Safety Advisory
Do not discontinue any prescribed medication without consulting your treating physician. Genetic test results must be integrated into the overall clinical picture and never used alone to alter treatment regimens.
Patient Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Active chemotherapy or blood transfusion within 2 weeks may affect DNA quality; alternative sample type (buccal swab) may be advised. This test is not indicated for asymptomatic individuals without a clinical indication of a neurodevelopmental disorder.
- Emergency Red Flags: If the patient experiences sudden neurological deterioration (uncontrolled seizures, loss of consciousness, acute weakness), seek immediate emergency care – this test is a scheduled diagnostic procedure, not an emergency intervention.
Patient FAQ & Clinical Guidance
1. What is the MTOR gene test and what conditions does it detect?
This advanced genomic test identifies disease‑causing mutations in the MTOR gene linked to neurodevelopmental conditions such as macrocephaly, intellectual disability, and epilepsy, enabling precise clinical diagnosis and personalized treatment planning.
2. How is the sample collected and what is the turnaround time?
A simple blood draw or finger‑prick FTA card collection is performed at home by a licensed phlebotomist via our VIP Mobile Phlebotomy service, with results ready in 3–4 weeks.
3. Is this test covered by UAE health insurance?
Most UAE insurance policies cover genetic testing for medically indicated neurodevelopmental disorders; direct billing verification is available via WhatsApp at +971 54 548 8731.
Pre‑requisite: A genetic counselling session and a pedigree chart of family members affected by MTOR‑related neurodevelopmental disorders are mandatory before sample collection.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance & Data Protection
DNA Labs UAE operates under DHA Facility License Number 1143 and complies fully with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient data is encrypted, access‑controlled, and processed solely for diagnostic purposes. Clinical safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.
All genetic results are de‑identified for research quality assurance and stored in compliance with UAE health data retention policies. Your privacy is safeguarded at every stage of the diagnostic pathway.
Clinical & Logistical Metadata
| Test Name | MTOR Gene Sequencing for Neurodevelopmental Disorders |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3-4 Weeks |
| Sample Type / Matrix | Whole Blood, DNA, or FTA Card |
| Methodology Used | Next‑Generation Sequencing (NGS) with Sanger Confirmation |
| ICD-10-CM Code | F89 (Unspecified disorder of psychological development) |
| LOINC Code | 82309-8 (DNA sequencing of gene) |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians